This is a non-core endpoint: only basic statistics are computed.
Multiple myeloma and malignant plasma cell neoplasms
CD2_MULTIPLE_MYELOMA_PLASMA_CELL
multiple myeloma: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1790 |
4. Check minimum number of eventsNone |
1790 |
5. Include endpointsNone |
1790 |
6. Filter based on genotype QC (FinnGen only) |
1729 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Myeloma multiplex et neoplasmata maligna plasmacytorum
Similar endpoints
↥List of similar endpoints to
Multiple myeloma and malignant plasma cell neoplasms
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1729 | 744 | 985 |
| Unadjusted period prevalence (%) | 0.37 | 0.26 | 0.45 |
| Median age at first event (years) | 69.66 | 68.63 | 70.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1790
- Matched controls
- 17900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
15.1
319.4
300
235
ZX112
NOMESCO Finland
Subcutaneous
21.7
307.7
293
160
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
40.3
307.7
325
98
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
5573.4
307.7
923
*
J05AB01
ATC
aciclovir; systemic
7.2
307.7
941
2379
329
Kela drug reimbursment
Lenalidomide
+∞
307.7
571
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
366.0
307.7
304
10
L03AA02
ATC
filgrastim; parenteral
33.5
307.7
547
232
H02AB02
ATC
dexamethasone; systemic
20.0
307.7
1065
1226
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
32.7
307.7
239
84
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
100.3
307.7
1264
419
A04AA01
ATC
ondansetron; systemic, rectal
11.8
307.7
631
791
153
Kela drug reimbursment
Lenalidomid
+∞
307.7
771
*
AA1AA
NOMESCO Finland
Head X-ray examination
66.6
307.7
262
46
L04AX04
ATC
lenalidomide; oral
+∞
307.7
746
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.3
307.7
479
518
M04AA01
ATC
allopurinol; systemic
8.2
307.7
888
1919
C90.0
ICD-10 Finland
Multiple myeloma
4503599627370496.0
307.7
1605
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
327.5
307.7
277
10
XW000
NOMESCO Finland
Bone marrow biopsy
39.3
307.7
855
407
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
174.0
307.7
201
13
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
15.5
299.0
275
207
B03XA02
ATC
darbepoetin alfa; parenteral
15.8
297.0
270
199
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
26.6
251.4
176
73
WW500
NOMESCO Finland
Blood transfusion
9.7
250.7
320
391
WF049
NOMESCO Finland
Radiotherapy of metastasis
10.3
244.1
295
335
M05BA02
ATC
clodronic acid; systemic
44.3
239.3
143
35
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
444.1
238.8
234
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.9
237.6
1151
4790
L01AA03
ATC
melphalan; systemic
1290.8
236.9
226
*
ZX108
NOMESCO Finland
Inhalation
41.9
236.0
143
37
N02AA05
ATC
oxycodone; systemic
4.9
234.7
806
2573
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
24.3
223.8
162
73
ZX120
NOMESCO Finland
Intravenous
5.8
207.6
464
1023
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
91.0
196.3
103
12
393
Kela drug reimbursment
Pomalidomide
+∞
195.5
184
*
L04AX06
ATC
pomalidomide; oral
+∞
193.3
182
*
B03XA01
ATC
erythropoietin; parenteral
24.1
185.2
134
60
1507
Kela drug reimbursment
Pomalidomide
+∞
183.6
173
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
9.6
182.0
227
266
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.0
179.1
263
376
R50.9
ICD-10 Finland
Fever, unspecified
4.4
173.5
568
1693
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.2
173.1
333
632
212
Kela drug reimbursment
Gout
10.8
169.5
192
197
J05AB11
ATC
valaciclovir; oral
4.5
167.6
516
1464
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
154.2
505
1492
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
152.3
144
*
L01AA01
ATC
cyclophosphamide; systemic
33.4
143.1
92
29
WW200
NOMESCO Finland
Immunization
10.0
136.8
162
176
YNB10
NOMESCO Finland
Collection of stem cells for transplant
1341.9
129.9
125
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
128.7
122
*
WW409
NOMESCO Finland
Other aferesis
235.4
128.7
131
6
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
21.5
127.5
96
47
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.2
123.2
386
1089
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.4
119.8
346
917
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.7
115.4
139
154
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.3
106.1
164
245
JN4AD
NOMESCO Finland
Body CT examination
3.8
105.4
390
1228
M05BX04
ATC
denosumab; parenteral
4.6
102.0
272
673
1XX32, ,
NOMESCO Finland
1034.9
101.2
98
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
26.5
99.7
69
27
B01AB05
ATC
enoxaparin; parenteral
2.8
97.7
848
4354
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.3
97.0
209
432
398
Kela drug reimbursment
Ixazomib
+∞
95.7
91
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
94.7
782
3900
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
11.1
92.4
100
95
D64.9
ICD-10 Finland
Anaemia, unspecified
3.4
92.3
416
1478
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
10.5
92.1
104
105
1505
Kela drug reimbursment
Ixazomib
+∞
90.4
86
*
B74
ICPC
Malignant neoplasm blood other
165.2
90.0
94
6
L04AX02
ATC
thalidomide; oral
454.3
87.9
87
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.7
87.3
219
514
J01MA12
ATC
levofloxacin; systemic
2.9
87.2
567
2476
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
13.9
85.7
80
60
E83.50
ICD-10 Finland
Hypercalcemia
11.2
85.0
91
85
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
36.4
84.6
53
15
5BA08, ,
NOMESCO Finland
18.3
83.0
67
38
WF004
NOMESCO Finland
Palliative radiotherapy
7.3
82.5
125
182
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
11.5
80.1
84
76
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
79.3
1129
7136
E85.9
ICD-10 Finland
Amyloidosis, unspecified
41.1
79.0
48
12
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.4
78.9
136
227
WW402
NOMESCO Finland
Leucoferesis
+∞
78.7
75
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
78.7
203
486
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
78.4
526
2317
GA5AA
NOMESCO Finland
Rib X-ray examination
21.4
77.1
58
28
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
32.1
77.0
50
16
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
75.6
72
*
B01AB10
ATC
tinzaparin; parenteral
3.4
75.1
319
1082
TK800
NOMESCO Finland
Hemodialysis
7.4
74.7
112
161
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
73.4
794
4378
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
72.4
69
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
71.9
164
354
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
20.2
71.4
55
28
C03CA01
ATC
furosemide; systemic
2.4
69.6
893
5276
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.4
68.6
187
466
J01MA14
ATC
moxifloxacin; systemic
3.3
67.0
286
969
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
10.3
67.0
76
77
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.2
66.0
116
197
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
24.8
64.9
46
19
127
Kela drug reimbursment
Transplant complication
9.2
64.7
80
91
A05AA02
ATC
ursodeoxycholic acid; oral
10.0
62.2
72
75
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
59.5
369
1537
A41.9
ICD-10 Finland
Sepsis, unspecified
4.5
58.8
153
367
Z52.89
ICD-10 Finland
Donor of other organ or tissue
206.8
58.4
60
*
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
57.6
55
*
A02BC02
ATC
pantoprazole; systemic
2.4
56.2
1364
10160
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
290.3
55.5
56
*
L01XG03
ATC
ixazomib; oral
+∞
55.5
53
*
Z51.5
ICD-10 Finland
Palliative care
3.0
55.1
283
1062
D70.89
ICD-10 Finland
Neutropenic splenomegaly
8.5
55.0
72
88
NF3AA
NOMESCO Finland
Femur X-ray examination
5.7
52.1
99
181
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
11.1
51.4
55
51
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
5.5
49.4
99
190
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
18.1
48.2
39
22
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.7
47.7
43
30
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.7
47.2
112
249
NB6AA
NOMESCO Finland
Humerus X-ray examination
5.3
45.9
94
184
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
45.6
298
1262
WVA20
NOMESCO Finland
Medicine administration
5.0
44.6
98
204
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
10.1
43.8
50
51
306
Kela drug reimbursment
Erythropoietin and darbepoetin
17.8
42.9
35
20
H02AB09
ATC
hydrocortisone; systemic
5.2
42.2
88
175
L01XX50
ATC
[U] ixazomib
+∞
41.8
40
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
41.2
509
2826
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
41.1
485
2645
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
40.6
763
4918
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
60.3
40.4
47
8
WZC15, ,
NOMESCO Finland
12.0
40.4
41
35
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.9
40.0
62
92
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
39.7
38
*
H02AB06
ATC
prednisolone; systemic
1.9
38.1
946
6641
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
36.6
35
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
36.4
283
1292
N17.8
ICD-10 Finland
Other acute renal failure
6.3
36.3
62
102
A79
ICPC
Malignancy NOS
5.8
35.8
66
117
A06AD11
ATC
lactulose; oral
2.1
35.5
406
2173
E85.89
ICD-10 Finland
Other amyloidosis
183.6
34.9
36
*
L01FC01
ATC
daratumumab; parenteral
+∞
34.5
33
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.1
34.4
99
255
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.0
33.2
32
25
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
32.6
166
614
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
9.7
32.5
38
40
N03AX16
ATC
[U] pregabalin
2.0
32.4
486
2857
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.4
32.4
83
196
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
31.9
179
696
A11CC03
ATC
alfacalcidol; systemic
4.2
31.0
84
207
N05CF01
ATC
zopiclone; oral
1.8
31.0
676
4471
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
9.2
30.4
37
41
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.1
30.4
53
89
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
30.3
29
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.3
30.2
120
384
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.1
30.2
86
220
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.6
30.2
58
107
N18.8
ICD-10 Finland
Other chronic renal failure
3.9
30.0
92
248
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
29.4
194
818
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
28.8
882
6399
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.8
28.4
88
239
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
10.2
28.3
32
32
1CX01, ,
NOMESCO Finland
56.0
28.2
33
6
EBA10
NOMESCO Finland
Operative extraction of tooth
2.5
28.1
188
797
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
27.7
244
1168
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
27.6
265
1314
ED1AA
NOMESCO Finland
Mandibular X-ray examination
10.2
27.4
31
31
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
27.1
26
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
27.1
838
6059
L04AD01
ATC
ciclosporin; systemic
5.4
27.1
54
103
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.6
27.1
163
656
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
63.0
27.0
31
5
ZXD05
NOMESCO Finland
Urgent procedure
1.8
26.7
576
3761
JN4BD
NOMESCO Finland
Extensive body CT
2.2
26.6
264
1326
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
26.3
234
1124
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
26.2
189
829
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.5
26.1
91
268
NB4AA
NOMESCO Finland
Scapula X-ray examination
9.8
25.9
30
31
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
8.6
25.8
33
39
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.9
25.8
46
79
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.4
25.8
43
69
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
25.5
519
3321
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.2
25.3
69
171
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
6.7
25.2
40
61
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
25.1
24
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
24.9
641
4381
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.0
24.7
53
108
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.8
24.7
45
79
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
28.0
24.5
33
12
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.8
24.5
76
207
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.5
24.4
86
255
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
35.0
24.3
31
9
3060, ,
Kela drug reimbursment
+∞
24.0
23
*
NA2AD
NOMESCO Finland
Thoracic spine CT examination
7.5
23.8
34
46
L03AA13
ATC
pegfilgrastim; parenteral
3.0
23.8
106
363
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
23.8
443
2753
5BA03, ,
NOMESCO Finland
+∞
23.0
22
*
1534, ,
Kela drug reimbursment
+∞
23.0
22
*
N19
ICD-10 Finland
Unspecified kidney failure
2.9
22.9
114
415
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
121.6
22.6
24
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
8.9
22.4
28
32
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.8
22.3
50
106
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.5
22.2
78
231
SPAT1088
SPAT
Blood transfusion
8.0
22.2
30
38
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
19.8
22.2
33
17
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
21.3
605
4206
A07AA02
ATC
nystatin; oral
2.4
21.1
146
627
WF099
NOMESCO Finland
Other radiotherapy
7.4
20.8
30
41
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
8.3
20.5
27
33
L03AB05
ATC
interferon alfa-2b; parenteral
18.5
20.4
31
17
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
20.2
205
1034
WZC30
NOMESCO Finland
Teaching
1.9
20.1
318
1870
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
17.5
20.0
31
18
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
106.2
19.6
21
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.1
19.5
41
82
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.1
19.3
80
263
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.6
19.2
64
183
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
18.9
293
1709
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
18.8
18
*
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
7.4
18.7
27
37
A07AA09
ATC
vancomycin; oral
4.4
18.3
46
107
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.1
18.1
38
76
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.4
18.1
135
600
SPAT1255
SPAT
Intravenous administration of medicine
2.2
18.1
157
744
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.9
17.7
255
1450
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
17.7
17
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
17.6
573
4080
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.3
17.4
45
107
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.3
17.3
65
201
ZX080
NOMESCO Finland
Image guided radiotherapy
3.4
16.9
61
184
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
63.9
16.8
19
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
63.9
16.8
19
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
35.4
16.7
21
6
N02BF02
ATC
pregabalin; oral
2.4
16.6
112
475
3XA02, ,
NOMESCO Finland
90.9
16.6
18
*
1AA01, ,
NOMESCO Finland
90.9
16.6
18
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
16.6
89
338
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
16.4
110
465
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
5.4
16.4
32
60
R80
ICD-10 Finland
Isolated proteinuria
5.9
16.2
29
50
A06AH03
ATC
naloxegol; oral
3.9
16.1
48
127
B02.9
ICD-10 Finland
Zoster without complication
2.2
16.1
149
723
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.5
16.1
55
160
B73
ICPC
Leukaemia
24.7
16.0
22
9
ZY010
NOMESCO Finland
Hospital outpatient
2.8
15.9
80
293
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
6.2
15.9
27
44
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
15.8
315
1971
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
60.6
15.8
18
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
15.8
116
512
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.1
15.8
33
66
9731/3-C42.1
ICD-O-3
Plasmacytoma, NOS, of bone marrow
85.9
15.6
17
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
11.8
15.6
28
24
H02AB07
ATC
prednisone; oral
1.8
15.3
270
1631
L01BB05
ATC
fludarabine; systemic
23.6
15.1
21
9
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.2
15.1
31
61
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.3
15.0
25
40
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.3
15.0
57
178
L04AA01
ATC
[U] ciclosporin
4.7
15.0
34
73
H26.3
ICD-10 Finland
Drug-induced cataract
6.6
14.9
24
37
A10AC01
ATC
insulin (human); parenteral
2.0
14.9
161
829
J02AC03
ATC
voriconazole; systemic
15.2
14.9
24
16
D64.8
ICD-10 Finland
Other specified anaemias
3.4
14.8
53
159
A28
ICPC
Limited function/disability NOS
1.6
14.7
391
2632
ECB20
NOMESCO Finland
Oral alveoplasty
4.6
14.7
35
78
Z3231
NOMESCO Finland
Registered nurse
1.6
14.7
498
3549
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.8
14.7
73
266
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.5
14.6
50
146
L71
ICPC
Malignant neoplasm musculoskeletal
36.3
14.4
18
5
A12AA04
ATC
calcium carbonate; oral
3.7
14.3
45
124
6BA02, ,
NOMESCO Finland
19.3
14.2
21
11
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
14.1
129
623
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
13.8
173
937
J01CA04
ATC
amoxicillin; systemic
1.5
13.8
1318
11550
L04AA06
ATC
mycophenolic acid; systemic
3.8
13.8
42
113
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.5
13.8
85
346
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.1
13.7
56
183
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
16.3
13.5
21
13
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
5.3
13.4
27
52
A41.8
ICD-10 Finland
Other specified sepsis
3.1
13.3
54
176
1XC02, ,
NOMESCO Finland
5.5
13.1
25
46
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
16.8
13.0
20
12
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
12.9
112
531
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
6.0
12.6
22
37
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
4.1
12.6
34
84
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
11.1
12.5
23
21
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
17.4
12.5
19
11
20399
ICD-8 Finland
Multiple myeloma
+∞
12.5
12
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
12.5
12
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
6.2
12.5
21
34
A02BC01
ATC
omeprazole; systemic
1.5
12.5
490
3587
A10AB05
ATC
insulin aspart; parenteral
1.9
12.4
151
811
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.8
12.3
62
228
JN4CD
NOMESCO Finland
Very extensive body CT
2.3
12.3
89
391
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
37.8
12.2
15
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
12.2
385
2687
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.1
12.0
25
50
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
11.9
64
244
H02AB04
ATC
methylprednisolone; systemic
1.7
11.8
253
1606
N02BE01
ATC
paracetamol; systemic, rectal
1.6
11.8
1533
14049
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
11.8
379
2652
L01AA02
ATC
chlorambucil; oral
9.7
11.7
23
24
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.3
11.5
43
133
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
11.5
11
*
TGC00
NOMESCO Finland
Bronchial lavation
2.7
11.4
62
238
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
11.3
321
2183
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.0
11.3
49
166
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
9.7
11.2
22
23
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.7
11.2
60
228
J12.8
ICD-10 Finland
Other viral pneumonia
4.5
11.2
27
61
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
20.2
11.1
16
8
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.3
11.0
28
66
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
10.1
11.0
21
21
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
4.4
11.0
27
62
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.3
11.0
41
127
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
10.8
119
617
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.0
10.8
47
160
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.2
10.6
86
397
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
11.3
10.5
19
17
C10AA07
ATC
rosuvastatin; oral
0.6
10.5
293
4170
ZXE00
NOMESCO Finland
One hour or less
1.4
10.5
637
5033
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
+∞
10.4
10
*
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
10.4
186
1125
M54.5
ICD-10 Finland
Low back pain
1.4
10.3
531
4072
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
10.2
288
1952
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
13.2
10.2
17
13
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.3
10.1
37
113
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
10.1
109
561
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
11.4
10.1
18
16
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
9.9
644
5134
3025
Kela drug reimbursment
Calcium carbonate
7.7
9.9
22
29
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.9
9.9
45
157
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
9.8
414
3051
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
9.8
328
2307
L01XE27
ATC
[U] ibrutinib
20.1
9.8
14
7
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.0
9.8
27
68
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
9.8
205
1293
WX720
NOMESCO Finland
Own respiration
2.1
9.8
88
424
N18.0
ICD-10 Finland
End-stage renal disease
3.7
9.7
30
82
N03AX12
ATC
[U] gabapentin; oral
1.6
9.7
277
1884
R06.0
ICD-10 Finland
Dyspnoea
1.4
9.6
491
3750
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.1
9.6
40
133
B99
ICPC
Blood/lymph/spleen disease other
8.4
9.6
20
24
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.5
706
5744
JN6AD
NOMESCO Finland
CT of torso and neck
3.3
9.5
35
108
JN4BG
NOMESCO Finland
Body MRI with high intensity magnet
+∞
9.4
9
*
9733/3-C42.1
ICD-O-3
Plasma cell leukemia of bone marrow
+∞
9.4
9
*
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
9.4
9
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
12.4
9.4
16
13
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
8.1
9.3
20
25
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
7.3
9.2
21
29
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
9.2
173
1060
390
Kela drug reimbursment
Ibrutinib
11.5
9.1
16
14
R93.7
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
15.7
9.0
14
9
E83.51
ICD-10 Finland
Hypocalcemia
7.1
9.0
21
30
372
Kela drug reimbursment
Idelalisib
36.9
9.0
11
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.9
9.0
26
68
V03AE01
ATC
polystyrene sulfonate; oral
3.2
8.9
35
112
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
24.1
8.9
12
5
L01BB02
ATC
mercaptopurine; oral
4.5
8.8
21
47
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
8.8
121
676
ZX100
NOMESCO Finland
Oral
3.1
8.7
36
119
M54.6
ICD-10 Finland
Pain in thoracic spine
1.9
8.7
102
542
WF002
NOMESCO Finland
Radical radiotherapy
1.9
8.6
113
622
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
8.6
283
1981
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
4.6
8.6
20
44
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.8
8.6
19
40
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
11.6
8.6
15
13
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
27.6
8.5
11
*
R11
ICD-10 Finland
Nausea and vomiting
1.7
8.4
141
836
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.1
8.4
78
380
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
8.4
392
2938
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
8.3
185
1183
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
8.3
8
*
1XX45, ,
NOMESCO Finland
+∞
8.3
8
*
GA5DA
NOMESCO Finland
Bilateral rib X-ray exmaination
+∞
8.3
8
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.0
8.3
35
117
1512
Kela drug reimbursment
Ibrutinib
10.8
8.3
15
14
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
8.3
131
765
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.1
8.3
22
54
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
8.2
106
582
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
8.2
200
1310
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
7.6
8.2
18
24
B34.9
ICD-10 Finland
Viral infection, unspecified
2.8
8.2
40
146
L01XX47
ATC
[U] idelalisib
33.5
8.1
10
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
11.7
8.1
14
12
J02AC01
ATC
fluconazole; systemic
1.4
8.0
502
3951
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.9
177
2666
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.9
7.9
36
126
B01.9
ICD-10 Finland
Varicella without complication
13.1
7.9
13
10
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
13.1
7.9
13
10
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
7.8
291
2085
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
7.8
126
739
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.8
674
5570
S42.3
ICD-10 Finland
Fracture of shaft of humerus
3.1
7.7
31
101
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
45.2
7.7
9
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
15.1
7.7
12
8
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.6
7.6
43
169
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
25.1
7.6
10
*
L04AD02
ATC
tacrolimus; systemic
4.1
7.5
20
49
J01DB01
ATC
cefalexin; oral
1.4
7.5
1327
12119
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.3
7.5
28
87
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
10.1
7.5
14
14
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.4
7.5
51
219
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
4.3
7.5
19
45
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.5
7.4
45
183
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
80.4
7.4
8
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
7.7
7.4
16
21
L01XX52
ATC
venetoclax; oral
9.4
7.3
14
15
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.4
7.3
50
216
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
15.8
7.2
11
7
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
7.2
1056
9356
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.0
7.1
73
370
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
7.1
190
1269
R06AE07
ATC
cetirizine; oral
1.3
7.1
598
4904
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
7.1
100
564
J01FF01
ATC
clindamycin; systemic
1.4
7.1
424
3301
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
4.1
7.1
19
47
DMW00
NOMESCO Finland
Intubation of maxillary antrum
12.1
7.1
12
10
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
7.0
74
379
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
7.0
281
2040
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
3.1
6.9
28
92
W0X00
NOMESCO Finland
Estimation of continuous need for medical therapy
13.8
6.9
11
8
A03
ICPC
Fever
1.5
6.9
193
1304
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.9
6.9
30
103
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.7
6.8
35
131
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
8.3
6.8
14
17
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.8
505
4066
S72.3
ICD-10 Finland
Fracture of shaft of femur
3.7
6.8
21
58
5AB14, ,
NOMESCO Finland
16.8
6.7
10
6
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
16.8
6.7
10
6
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
6.7
64
317
C10AC01
ATC
colestyramine; oral
2.4
6.7
44
187
C08CA01
ATC
amlodipine; oral
1.3
6.6
724
6140
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.7
6.6
20
54
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
6.4
6.6
16
25
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
6.4
6.6
16
25
D69.5
ICD-10 Finland
Secondary thrombocytopenia
7.8
6.6
14
18
L28
ICPC
Limited function/disability (L)
1.4
6.6
336
2545
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
5.5
6.6
18
33
L03AA04, ,
ATC
8.7
6.6
13
15
NB3AA
NOMESCO Finland
Clavicle X-ray examination
3.0
6.5
27
90
R4110
NOMESCO Finland
Physiotherapy
1.3
6.5
450
3579
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
6.5
120
733
N06DA02
ATC
donepezil; oral
0.4
6.5
38
856
L03AA10
ATC
lenograstim; parenteral
70.1
6.4
7
*
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
14.4
6.4
10
7
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.8
6.4
19
51
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
6.4
78
422
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
6.3
284
2105
A98
ICPC
Health maint/preventive medicine
0.7
6.3
1414
14977
M907, C6488,
ICD-10 Finland
+∞
6.3
6
*
9731/3-C41.4
ICD-O-3
Plasmacytoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
6.3
6
*
B01.8
ICD-10 Finland
Varicella with other complications
+∞
6.3
6
*
9731/3-C41.9
ICD-O-3
Plasmacytoma, NOS, of bone, NOS
+∞
6.3
6
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
6.3
6
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
26.8
6.2
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
2.8
6.2
30
109
A04AA02
ATC
granisetron; systemic, transdermal
1.7
6.2
105
626
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.2
200
1393
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
3.5
6.2
20
57
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.2
6.2
23
72
399
Kela drug reimbursment
Venetoclax
7.7
6.1
13
17
NF3AD
NOMESCO Finland
Femur CT
7.7
6.1
13
17
N06DX01
ATC
memantine; oral
0.5
6.1
59
1114
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.0
6.1
59
294
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.1
6.1
52
247
K10.21
ICD-10 Finland
Osteoradionecrosis of jaw (acute)(chronic)(suppurative)
8.6
6.1
12
14
S72.2
ICD-10 Finland
Subtrochanteric fracture
3.6
6.0
19
53
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.6
6.0
19
53
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
395
482
10.23
312.36
19.6
1.5
0.00
0.00
g/l
-0.00
385
442
832
817
18.16
307.65
5.9
1.7
0.81
1.64
g/l
5.02
701
742
655
629
15.85
307.65
16.6
1.5
2.56
3.05
g/l
18.49
638
554
982
1023
20.05
307.65
10.4
2.4
12.91
10.54
g/l
7.36
938
931
920
2338
7.04
307.65
7.1
1.3
3.22
2.67
g/l
1.60
806
1343
1149
1450
20.34
307.65
19.4
1.9
67.48
66.26
g/l
3.20
1128
1310
340
281
14.70
307.65
5.8
6.2
319.92
853.26
iu/ml
0.68
74
47
717
677
17.00
307.65
15.7
1.5
—
—
—
0
0
1090
555
48.66
307.65
18.8
1.7
125.78
35.74
mg/l
6.29
943
460
822
1562
8.88
307.65
4.4
2.5
61.59
68.60
e9/l
5.93
665
1213
1090
553
48.85
307.65
18.8
1.7
233.50
45.98
mg/l
2.08
944
456
409
487
10.59
307.65
19.0
1.5
0.01
0.00
g/l
1.21
385
443
717
678
16.97
307.65
15.7
1.5
7.03
7.49
g/l
7.24
700
603
940
2085
8.39
307.65
4.7
2.4
1.67
1.80
%
3.49
900
1838
707
572
19.78
307.65
15.3
1.7
7.27
0.75
g/l
39.01
585
488
1110
1977
13.15
307.65
11.4
3.7
228.25
248.91
u/l
3.19
1090
1857
664
286
36.32
307.65
1.7
1.5
—
—
—
0
0
716
676
16.99
307.65
15.7
1.5
3.75
3.74
g/l
0.03
699
601
854
2211
6.47
307.65
10.6
5.4
1.09
1.03
mmol/l
5.28
825
2030
620
642
14.24
307.65
17.0
1.5
10.83
10.47
g/l
0.40
592
564
438
547
10.28
307.65
18.2
1.5
37.60
37.22
g/l
0.59
410
473
214
22
110.35
307.65
1.2
1.4
—
—
—
0
0
497
167
40.82
307.65
4.8
2.0
1.00
1.62
g/24h
0.74
281
81
1074
538
48.41
307.65
18.2
1.7
25.53
1.48
ratio
2.22
87
43
455
511
11.60
307.65
18.0
1.5
0.20
0.01
g/l
3.05
425
465
1105
4047
5.52
281.17
9.0
2.8
3407.57
7542.42
umol/l
1.70
1068
3456
141
12
127.46
279.01
3.8
1.3
—
—
—
0
0
133
15
95.70
255.13
9.8
1.6
—
—
—
0
0
304
373
9.61
236.91
2.6
1.7
—
—
—
0
0
233
9
297.30
233.40
1.4
1.0
—
—
—
0
0
307
390
9.29
232.64
2.6
1.7
—
—
—
0
0
242
260
10.61
207.63
2.7
1.6
—
—
—
0
0
242
260
10.61
207.63
2.7
1.6
—
—
—
0
0
777
2622
4.47
205.78
5.8
3.2
0.80
0.81
mmol/l
1.83
747
2441
300
447
7.86
197.67
1.8
1.5
—
—
—
0
0
238
271
9.98
195.35
1.4
1.2
85.73
39.16
u/l
2.70
227
233
242
286
9.63
193.03
2.7
1.8
—
—
—
0
0
232
279
9.40
182.32
4.4
3.8
1.79
1.54
%
0.33
215
249
213
229
10.42
182.13
2.5
3.1
211.77
2039.05
u/ml
0.93
13
22
460
1142
5.08
177.43
8.9
3.8
0.74
0.69
%
0.17
340
414
470
1190
5.00
177.00
8.7
4.0
0.13
0.10
%
0.53
347
410
1286
6778
4.19
169.94
17.8
6.1
9.66
8.93
%
10.13
1261
6300
1283
6754
4.18
169.78
16.9
5.8
2.64
2.84
%
2.61
1257
6270
1324
7142
4.28
168.56
17.0
5.5
0.55
0.62
e9/l
17.87
1229
6074
1325
7162
4.27
167.91
17.0
5.6
0.03
0.04
e9/l
31.59
1228
6094
1256
6571
4.06
166.40
16.5
5.8
0.63
0.66
%
0.55
1228
6096
461
1211
4.78
164.97
2.3
1.6
—
—
—
0
0
1289
6898
4.10
164.24
17.2
6.0
28.87
26.25
%
9.95
1263
6424
1329
7307
4.18
161.56
17.1
5.6
1.77
1.91
e9/l
0.74
1250
6376
1271
6784
4.01
161.45
15.8
5.8
54.44
58.38
%
20.59
1243
6316
1338
7397
4.20
161.18
17.9
5.8
0.15
0.19
e9/l
24.95
1249
6396
374
854
5.27
158.01
2.3
1.7
1.39
1.55
g/l
2.44
335
735
169
164
11.27
154.88
3.0
1.7
—
—
—
0
0
171
175
10.70
150.96
3.0
1.7
—
—
—
0
0
731
2859
3.63
147.70
3.2
1.9
—
—
—
0
0
674
2544
3.65
143.15
3.0
2.1
28.75
30.05
s
6.58
653
2458
148
141
11.35
137.10
3.2
1.6
—
—
—
0
0
148
141
11.35
137.10
3.2
1.6
—
—
—
0
0
148
141
11.35
137.10
3.2
1.6
—
—
—
0
0
175
213
9.00
135.40
1.4
1.5
122.25
133.50
u/ml
0.15
46
35
112
68
17.50
134.83
3.7
1.9
—
—
—
0
0
1350
8018
3.78
134.11
34.3
6.6
1.21
1.21
mmol/l
0.08
1188
6786
111
67
17.60
134.00
3.6
1.9
—
—
—
0
0
111
67
17.60
134.00
3.6
1.9
—
—
—
0
0
122
89
14.64
133.27
2.0
2.9
32.55
40.64
%
1.70
40
56
1234
6956
3.49
132.81
13.5
4.8
33.34
34.70
g/l
12.76
1199
6445
158
175
9.81
131.40
4.6
3.5
57.80
56.85
%
0.17
141
151
1375
8347
3.79
130.02
39.9
8.7
3.17
4.27
e9/l
78.49
1291
7219
84
28
31.43
128.31
2.1
1.2
—
—
—
0
0
118
88
14.28
127.23
3.6
1.8
—
—
—
0
0
118
88
14.28
127.23
3.6
1.8
—
—
—
0
0
477
1559
3.81
123.70
10.1
6.7
12.40
10.63
mmol/l
4.54
461
1473
258
540
5.41
118.86
1.7
1.3
—
—
—
0
0
189
294
7.07
118.05
1.3
1.3
—
—
—
0
0
1313
8013
3.40
117.04
18.6
6.3
10.24
12.12
umol/l
11.33
1297
7598
606
2386
3.33
116.63
3.3
2.5
2.10
2.28
g/l
12.44
580
2199
1238
7336
3.23
115.34
26.9
5.9
1.21
1.21
mmol/l
1.71
1208
6628
147
176
9.01
114.93
4.2
2.6
—
—
—
0
0
585
2273
3.34
114.83
3.4
2.5
24.62
22.05
%
3.99
516
1932
161
228
7.66
109.35
1.7
1.2
—
—
—
0
0
120
118
10.83
108.47
1.1
1.0
—
—
—
0
0
113
102
11.76
108.21
1.2
1.2
—
—
—
0
0
621
2586
3.15
107.35
3.3
2.5
12.80
12.37
umol/l
0.83
597
2400
109
99
11.66
103.91
1.3
1.1
—
—
—
0
0
518
1991
3.25
101.95
2.4
1.8
—
—
—
0
0
507
1985
3.17
96.03
2.5
1.8
—
—
—
0
0
129
174
7.91
91.17
1.8
1.5
—
—
—
0
0
129
174
7.91
91.17
1.8
1.5
—
—
—
0
0
143
227
6.76
87.17
1.8
1.7
—
—
—
0
0
82
68
12.59
82.68
2.2
5.1
—
44.00
—
0
13
931
5371
2.53
79.79
8.4
3.4
2.32
2.35
mmol/l
4.59
859
4621
151
277
5.86
79.52
1.6
1.5
—
—
—
0
0
90
93
10.14
78.32
1.6
1.4
—
—
—
0
0
90
93
10.14
78.32
1.6
1.4
—
—
—
0
0
121
183
7.02
77.07
1.8
1.7
—
—
—
0
0
87
90
10.11
75.62
3.5
3.9
—
—
—
0
0
177
398
4.83
74.00
3.5
2.4
3.71
3.57
g/l
0.55
172
375
352
1289
3.15
72.86
4.3
3.8
97.21
96.73
ng/l
0.03
310
1106
132
244
5.76
68.82
1.7
1.4
—
—
—
0
0
249
770
3.59
67.40
2.5
1.9
2.21
2.42
ug/l
0.09
227
670
80
91
9.16
64.73
2.3
2.0
18.24
16.20
%
0.59
75
86
77
85
9.42
63.73
2.3
1.4
—
—
—
0
0
77
85
9.42
63.73
2.3
1.4
—
—
—
0
0
86
110
8.16
63.35
2.2
1.4
—
—
—
0
0
937
5810
2.29
63.19
3.9
2.8
313.72
156.54
ug/l
13.40
886
5240
118
216
5.78
62.08
1.5
1.2
229.03
284.30
u/ml
0.70
68
121
85
110
8.06
62.00
2.2
1.4
—
—
—
0
0
118
217
5.75
61.78
1.6
1.5
—
—
—
0
0
1276
9138
2.38
59.20
14.2
4.9
6.64
6.87
mmol/l
4.38
1242
8623
731
4176
2.27
59.00
2.3
2.2
2.89
3.07
mg/l
1.06
631
3514
82
109
7.84
58.45
1.2
1.3
—
—
—
0
0
118
231
5.40
57.69
1.5
1.5
—
—
—
0
0
73
88
8.61
56.39
2.2
2.0
—
—
—
0
0
1047
6992
2.20
56.35
6.6
2.6
—
—
—
0
0
71
83
8.87
56.20
3.0
1.7
—
—
—
0
0
72
89
8.39
54.50
3.5
2.1
645.27
550.90
e6/l
0.33
62
77
69
87
8.21
51.37
3.7
2.1
0.25
0.21
e9/l
0.57
61
77
109
224
5.12
50.39
5.5
6.2
10.60
12.19
mg/l
2.86
100
206
377
1714
2.52
50.13
7.3
2.7
6.96
9.76
umol/l
1.40
340
1510
66
82
8.32
49.73
1.2
1.3
—
—
—
0
0
840
5331
2.08
49.37
4.8
3.2
1871.81
1710.75
ng/l
0.50
768
4631
653
3778
2.15
48.97
6.4
2.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
195
629
3.36
48.87
3.2
2.9
0.32
0.36
u/ml
0.76
115
366
131
334
4.15
46.31
2.3
1.4
—
—
—
0
0
99
204
5.08
45.59
2.5
1.5
—
—
—
0
0
99
204
5.08
45.59
2.5
1.5
—
—
—
0
0
100
208
5.03
45.56
2.5
1.5
—
—
—
0
0
99
206
5.03
45.08
2.5
1.5
—
—
—
0
0
99
207
5.00
44.83
2.5
1.5
—
—
—
0
0
351
1622
2.45
44.60
6.7
3.6
1.39
2.02
mmol/l
2.23
295
1332
98
206
4.97
44.10
2.6
1.5
—
—
—
0
0
873
5788
1.99
43.73
4.3
3.4
—
—
—
0
0
349
1627
2.42
43.39
6.8
3.5
5.69
5.83
kpa
2.00
344
1575
547
3071
2.12
43.37
2.4
1.6
1.44
1.47
mg/l
0.06
453
2401
764
4865
2.00
42.67
4.3
3.5
43.07
88.77
e6/l
1.43
648
3848
249
996
2.74
42.49
1.7
1.5
—
—
—
0
0
43
38
11.57
41.45
1.9
1.6
—
—
—
0
0
201
730
2.98
41.00
4.5
2.0
—
—
—
0
0
74
130
5.89
40.53
1.4
1.7
—
—
—
0
0
258
1076
2.63
40.44
5.3
3.9
0.93
2.00
mmol/l
4.11
185
799
660
4052
2.00
40.39
1.9
1.6
18.57
20.10
nmol/l
1.86
619
3398
44
42
10.71
40.30
4.2
2.0
—
—
—
0
0
134
389
3.64
39.35
3.8
3.4
1.84
1.72
mg/l
0.65
122
348
293
1317
2.46
39.18
19.4
3.9
1.22
1.22
mmol/l
1.16
287
1132
633
3864
1.99
39.11
7.1
4.1
87.74
85.10
%
1.85
620
3763
265
1139
2.56
38.97
5.4
3.9
4.82
5.18
kpa
8.85
249
1080
704
4470
1.95
38.66
4.3
3.4
0.44
0.48
e6/l
0.20
593
3492
906
6259
1.91
38.45
28.8
10.2
0.01
0.00
e9/l
0.74
790
5065
113
298
3.98
38.08
8.2
3.4
48.93
59.31
%
8.60
113
298
259
1125
2.52
37.16
2.4
1.7
—
—
—
0
0
109
285
4.01
37.16
6.7
3.1
2.86
4.47
e9/l
13.36
109
285
817
5500
1.89
37.14
5.0
4.0
77.29
117.48
e6/l
1.17
670
4095
72
134
5.56
37.11
1.9
1.7
—
—
—
0
0
283
1282
2.43
37.07
2.2
2.2
388.56
370.47
nmol/l
0.72
270
1153
1076
7976
1.88
35.48
17.3
18.8
1.28
1.35
inr
0.54
304
2240
200
811
2.65
32.90
7.5
3.7
23.72
24.06
mmol/l
0.72
200
787
1405
11502
2.03
32.75
29.0
7.7
78.15
80.34
u/l
1.02
1388
10769
562
3463
1.91
32.57
3.3
2.7
5.37
4.81
e6/l
0.58
528
3131
119
386
3.23
29.30
1.8
1.4
1.12
1.16
g/l
0.73
111
371
542
3410
1.85
28.78
1.9
1.8
1161.98
1157.13
nmol/l
0.04
441
2538
115
370
3.25
28.69
1.8
1.5
0.24
0.24
g/l
0.05
104
354
166
672
2.62
27.27
3.0
1.9
—
—
—
0
0
505
3165
1.83
26.83
5.7
3.1
2.49
2.46
mmol/l
3.67
461
2774
169
699
2.57
26.55
6.3
4.2
24.10
24.91
mmol/l
3.12
156
650
41
64
6.53
25.23
1.1
1.2
—
—
—
0
0
110
374
3.07
25.00
1.5
1.3
—
—
—
0
0
110
374
3.07
25.00
1.5
1.3
—
—
—
0
0
909
6818
1.68
24.88
2.5
2.1
90.87
93.97
pmol/l
1.22
624
3532
59
132
4.59
24.63
1.2
1.1
—
—
—
0
0
70
180
4.01
24.41
1.2
1.3
204.28
200.55
miu/ml
0.02
23
61
52
111
4.79
22.97
1.7
1.5
—
—
—
0
0
808
5965
1.65
22.85
2.7
2.2
81.82
78.99
nmol/l
1.88
751
5193
843
6297
1.64
22.70
5.6
4.1
40.48
56.66
ng/l
1.19
730
4837
1289
10749
1.71
22.26
8.3
4.2
33.00
13.94
mm/h
77.53
1236
9827
441
2787
1.77
22.15
3.6
2.9
1.11
1.21
e6/l
0.22
271
1660
32
44
7.39
22.08
1.1
1.2
—
—
—
0
0
46
93
5.05
21.65
1.7
1.6
—
—
—
0
0
1206
9930
1.66
21.35
6.1
4.9
453.68
1839.70
e6/l
1.16
19
169
416
2617
1.77
21.09
3.8
3.1
2.18
2.01
e6/l
0.18
246
1502
45
93
4.94
20.66
1.8
1.6
—
—
—
0
0
76
235
3.33
20.22
1.1
1.1
—
—
—
0
0
890
6863
1.59
20.14
3.2
2.4
—
—
—
0
0
266
1481
1.94
19.86
7.1
6.7
1.24
1.41
mmol/l
2.64
259
1443
29
15
19.63
19.52
1.4
1.1
—
—
—
0
0
306
1799
1.85
19.27
7.5
7.3
94.91
95.43
%
0.59
291
1726
244
1334
1.96
19.18
5.6
2.9
4.62
4.52
kpa
0.26
239
1287
332
2006
1.80
19.11
7.3
6.9
4.88
5.09
kpa
2.55
313
1904
331
2007
1.80
18.80
7.3
6.9
11.57
11.91
kpa
0.64
312
1909
26
34
7.75
18.71
1.2
1.1
1006.38
1705.29
miu/ml
1.54
26
34
1242
14083
0.61
18.62
4.7
5.4
2.52
2.59
mmol/l
2.06
1140
12675
651
4727
1.59
18.61
2.9
2.6
60.94
76.99
u/l
0.44
618
4338
331
2013
1.79
18.60
7.2
6.9
0.65
1.14
mmol/l
1.07
250
1570
133
580
2.40
18.57
1.3
1.9
34.36
37.94
u/l
1.00
122
498
97
363
2.77
18.54
3.3
2.5
14.45
15.96
%
3.10
56
186
280
1639
1.84
17.79
8.1
7.6
107.17
121.23
g/l
25.50
272
1588
28
45
6.31
16.76
1.5
1.2
—
—
—
0
0
196
1064
1.95
15.62
5.6
3.1
110.31
127.36
g/l
20.34
190
1036
464
3246
1.58
14.91
5.8
4.1
137.86
644.11
ng/l
1.19
408
2777
602
4465
1.52
14.86
5.9
3.2
35.91
36.08
u/l
0.02
581
4230
32
67
4.84
14.51
2.0
2.2
2344.25
1516.48
u/ml
0.27
32
67
26
45
5.85
14.47
2.5
2.2
38.24
27.95
%
1.44
21
40
90
368
2.52
14.46
1.3
2.0
15.06
12.32
mg/l
1.29
85
334
878
7069
1.48
14.33
4.3
4.0
0.01
0.00
estimate
0.35
212
1431
131
634
2.15
14.28
2.7
2.8
—
—
—
0
0
1208
13585
0.66
14.27
4.3
4.7
1.35
1.44
mmol/l
10.89
1109
12187
1224
13720
0.66
14.10
4.4
4.8
4.36
4.48
mmol/l
3.07
1130
12415
883
7139
1.47
13.97
4.4
4.0
0.00
0.00
estimate
0.80
192
1288
873
7047
1.47
13.90
5.9
5.3
0.00
0.00
estimate
-0.00
199
1326
105
471
2.31
13.76
3.5
3.4
23.46
25.20
mmol/l
3.58
99
460
1242
13858
0.66
13.65
5.5
5.1
6.12
6.08
mmol/l
0.41
1126
12328
29
60
4.90
13.34
1.1
1.6
—
—
—
0
0
89
379
2.42
13.12
4.3
5.3
2.45
2.66
mmol/l
0.35
65
268
1189
13352
0.67
13.09
6.4
6.5
40.87
40.81
mmol/mol
0.07
1098
12118
88
374
2.42
13.03
3.1
2.2
114.78
128.20
g/l
5.24
67
275
136
700
2.02
12.59
7.3
5.1
0.87
0.89
%
0.14
129
652
136
710
1.99
12.10
7.3
5.0
1.64
1.61
%
0.14
128
661
30
70
4.34
11.96
1.0
1.0
—
—
—
0
0
28
65
4.36
11.24
1.2
1.2
—
—
—
0
0
27
66
4.14
10.17
10.0
3.2
200.52
214.86
u/l
0.64
27
66
20
39
5.17
9.84
1.4
1.2
—
—
—
0
0
19
37
5.18
9.36
1.6
1.4
—
—
—
0
0
149
872
1.77
9.32
3.0
2.9
0.29
0.32
e6/l
0.10
149
858
155
922
1.75
9.16
8.3
9.0
23.63
24.37
mmol/l
1.47
144
891
47
176
2.72
9.09
1.5
1.4
—
—
—
0
0
113
619
1.88
8.76
2.9
2.3
725.72
554.12
ug/l
0.26
106
579
256
1752
1.54
8.64
5.1
3.7
—
—
—
0
0
60
262
2.33
8.46
1.3
1.3
—
—
—
0
0
1199
13158
0.73
8.43
4.3
4.2
1.39
1.28
mmol/l
2.43
1097
11690
26
72
3.65
8.29
1.2
1.2
—
—
—
0
0
278
3824
0.68
8.08
1.6
1.6
1.65
1.34
mmol/l
1.98
248
3130
61
275
2.26
8.01
1.4
1.5
30.10
31.18
g/l
0.21
54
247
173
1105
1.63
7.84
7.6
6.6
23.87
24.48
mmol/l
1.11
163
1048
20
34
5.94
7.68
1.7
1.4
112.40
139.75
titre
—
5
8
188
1237
1.58
7.53
5.1
2.9
51.26
61.86
ml/min/173m2
4.07
114
526
14
14
10.07
7.53
1.5
1.1
95.86
89.36
%
0.21
14
14
17
24
7.14
7.48
1.4
1.8
—
—
—
0
0
255
1809
1.48
7.20
2.8
4.1
5.39
19.78
ug/l
2.25
202
1506
16
24
6.72
6.81
1.7
1.9
—
—
—
0
0
74
384
1.97
6.80
1.3
1.4
—
—
—
0
0
49
223
2.23
6.35
3.7
3.6
97.12
35.69
u/ml
0.64
49
218
13
17
7.69
6.12
11.7
10.5
4.85
5.75
mmol/l
0.55
13
17
16
29
5.56
5.99
1.0
1.0
—
—
—
0
0
223
1607
1.44
5.78
3.9
3.0
281.39
236.19
ng/l
0.70
204
1473
52
255
2.07
5.63
1.4
1.4
946.68
1639.04
e6/l
2.08
38
185
44
202
2.21
5.62
5.6
6.3
6.94
7.59
mmol/l
0.62
34
173
114
715
1.63
5.60
3.7
3.3
4.37
4.36
pmol/l
0.04
106
615
66
354
1.90
5.56
1.5
1.6
—
—
—
0
0
10
10
10.05
5.53
2.0
4.7
—
—
—
0
0
34
141
2.44
5.47
1.4
1.2
11.29
12.12
u/l
0.13
28
132
8
5
16.07
5.41
1.8
3.6
—
—
—
0
0
8
5
16.07
5.41
1.4
1.2
—
—
—
0
0
82
477
1.75
5.33
1.8
1.7
—
—
—
0
0
73
411
1.81
5.30
1.4
1.6
0.21
15.68
iu/ml
0.56
17
86
68
375
1.85
5.27
2.0
2.6
27.13
33.70
umol/l
2.33
56
331
73
412
1.80
5.26
1.2
1.2
—
—
—
0
0
43
204
2.14
5.10
1.6
1.6
16.27
21.27
ug/l
0.99
43
199
72
409
1.79
5.09
1.2
1.2
—
—
—
0
0
14
27
5.22
5.08
1.1
1.1
—
—
—
0
0
581
4932
1.26
4.92
2.4
2.2
163.16
231.94
u/l
2.06
550
4601
191
1380
1.43
4.89
2.2
2.1
168.19
158.42
ug/g
0.09
156
1096
68
390
1.77
4.68
9.5
6.7
105.41
105.44
mmol/l
0.01
61
345
470
3913
1.27
4.64
4.8
4.3
0.00
0.00
estimate
0.50
164
1261
1463
15301
0.76
4.61
73.3
25.0
118.45
133.55
g/l
189.56
1445
15006
1462
15291
0.76
4.59
72.7
25.0
35.68
39.54
%
95.13
1356
14086
24
92
2.63
4.57
1.4
1.2
42.38
20.18
u/l
1.16
24
80
1463
15298
0.76
4.57
72.8
24.9
3.84
4.42
e12/l
201.72
1434
14769
1463
15296
0.76
4.54
73.0
24.9
199.55
241.47
e9/l
77.71
1435
14820
1463
15295
0.76
4.53
72.9
24.9
6.34
6.87
e9/l
3.12
1434
14762
99
639
1.58
4.38
2.4
3.4
612.99
7525.69
u/ml
0.90
82
544
199
1480
1.39
4.33
1.4
1.3
—
—
—
0
0
7
6
11.71
4.27
1.4
1.2
—
—
—
0
0
24
97
2.49
4.13
1.4
1.1
121.46
88.21
u/l
0.61
24
86
620
5388
1.23
4.10
4.8
4.3
—
—
—
0
0
20
74
2.72
4.09
1.3
1.0
—
—
—
0
0
38
191
2.01
3.94
2.8
3.8
—
—
—
0
0
34
165
2.08
3.87
1.1
1.1
—
15.83
—
0
7
72
445
1.64
3.84
1.4
1.5
223.51
274.27
ug/g
1.37
42
272
63
376
1.70
3.83
7.1
3.4
7.38
7.72
mmol/l
0.47
63
367
43
231
1.88
3.71
1.4
1.4
71803.71
88617.22
e6/l
0.14
24
140
7
9
7.80
3.56
1.4
1.1
—
—
—
0
0
187
1428
1.35
3.47
2.8
2.4
56.33
39.65
u/l
0.63
153
1208
33
166
2.01
3.45
1.1
1.2
1.50
3.82
u/ml
—
10
51
8
14
5.73
3.34
1.3
1.1
—
—
—
0
0
32
162
1.99
3.30
1.1
1.1
3.09
6.17
u/ml
0.87
11
78
7
11
6.38
3.18
1.0
1.0
—
—
—
0
0
15
355
0.42
3.03
1.3
1.6
1.16
3.10
mg/l
—
7
285
49
294
1.69
2.99
1.2
1.1
—
—
—
0
0
5
5
10.02
2.98
1.6
1.0
—
—
—
0
0
560
4943
1.19
2.97
7.5
3.3
7442.16
231.33
mg/l
21.03
445
3176
80
545
1.49
2.87
1.2
1.2
—
—
—
0
0
12
38
3.17
2.85
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
77
2.35
2.82
1.1
1.2
—
—
—
0
0
7
14
5.01
2.73
1.1
1.0
—
—
—
0
0
67
445
1.53
2.73
1.1
1.2
0.32
0.98
u/ml
—
5
34
14
54
2.61
2.70
1.2
1.3
22.56
23.51
%
—
9
41
9
24
3.76
2.67
1.0
1.1
—
—
—
0
0
17
74
2.31
2.58
1.0
1.1
—
—
—
0
0
19
87
2.20
2.57
1.3
1.5
16.78
14.91
umol/l
0.35
19
81
309
2625
1.21
2.44
1.3
1.2
0.96
1.52
u/ml
1.07
40
667
1455
14019
1.20
2.41
55.6
16.9
21.04
26.90
mg/l
12.33
1380
11421
1437
14855
0.83
2.37
36.3
11.3
26.26
25.51
u/l
0.69
1417
14216
24
434
0.55
2.32
1.5
1.5
—
—
—
0
0
191
1555
1.26
2.25
2.4
2.1
0.19
0.20
g/l
0.93
180
1441
7
18
3.90
2.25
1.0
1.4
—
—
—
0
0
45
287
1.58
2.23
1.2
1.3
—
—
—
0
0
28
478
0.58
2.21
1.6
1.6
—
—
—
0
0
14
61
2.31
2.14
1.0
1.2
—
—
—
0
0
30
174
1.74
2.14
1.4
1.4
277.63
276.00
mosm/kgh2o
0.10
24
124
18
88
2.06
2.11
3.9
3.8
—
—
—
0
0
5
10
5.01
2.07
1.2
1.0
—
—
—
0
0
8
26
3.09
2.01
1.3
1.1
—
—
—
0
0
31
186
1.68
1.98
1.4
1.6
70.05
62.73
%
0.53
20
124
17
84
2.03
1.95
1.7
1.5
0.92
2.99
u/field
1.99
12
59
58
405
1.45
1.93
1.7
1.7
19285.61
13938.40
e6/l
0.60
41
296
20
106
1.90
1.91
1.0
1.2
—
—
—
0
0
1235
12853
0.87
1.89
5.1
4.7
2.11
2.12
mu/l
0.02
1151
11479
108
1372
0.77
1.84
1.3
1.3
—
—
—
0
0
58
413
1.42
1.76
1.6
1.7
—
—
—
0
0
321
3638
0.86
1.76
2.9
3.3
0.98
0.78
ug/l
1.42
233
2553
191
1602
1.22
1.75
2.8
2.5
5.99
7.29
ug/l
0.53
167
1394
30
186
1.62
1.72
1.6
1.5
—
—
—
0
0
10
40
2.51
1.66
1.2
1.1
—
—
—
0
0
10
41
2.45
1.64
1.2
1.1
—
—
—
0
0
10
41
2.45
1.64
1.2
1.1
—
—
—
0
0
10
43
2.33
1.58
1.2
1.1
—
—
—
0
0
26
160
1.63
1.56
1.1
1.1
—
—
—
0
0
10
44
2.28
1.55
1.2
1.1
—
—
—
0
0
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
60
443
1.37
1.52
1.4
1.4
—
—
—
0
0
61
454
1.36
1.47
2.6
3.3
0.77
0.82
nmol/l
0.52
39
355
17
94
1.82
1.47
2.3
2.4
—
—
—
0
0
1454
14897
0.87
1.46
57.1
20.3
3.99
4.00
mmol/l
0.55
1436
14474
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
42
295
1.43
1.42
1.5
1.3
9.88
39.20
e6/l
0.78
33
231
42
295
1.43
1.42
1.5
1.4
28.31
616.15
e6/l
0.95
32
241
14
74
1.90
1.39
1.7
1.8
237.66
4109.02
u/l
—
7
22
6
23
2.61
1.37
1.0
1.2
—
—
—
0
0
353
3181
1.14
1.36
4.6
4.4
1.02
1.02
kg/l
0.24
59
480
22
135
1.64
1.36
1.9
2.3
613.53
659.93
ml
0.28
17
84
5
17
2.95
1.36
1.4
1.1
—
—
—
0
0
1291
13305
0.89
1.35
44.0
16.1
68.36
74.13
ml/min/173m2
14.07
1168
11039
52
695
0.74
1.34
1.7
1.8
—
—
—
0
0
9
43
2.10
1.30
1.2
1.7
39.97
205.32
ug/l
—
9
37
8
34
2.36
1.29
1.9
2.0
1.17
1.20
mmol/l
—
8
34
5
18
2.78
1.28
1.2
1.3
—
—
—
0
0
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
1454
14867
0.88
1.26
52.6
20.1
138.89
139.62
mmol/l
22.64
1436
14462
22
138
1.60
1.26
1.9
2.1
0.50
2.11
u/field
—
10
47
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
41
303
1.36
1.09
1.3
1.3
3.76
3.90
mmol/l
0.15
36
282
12
205
0.58
1.06
1.8
1.4
—
—
—
0
0
86
708
1.23
1.03
1.4
1.2
86.64
196.98
u/ml
3.58
79
646
7
34
2.06
1.03
1.1
3.1
13.76
14.90
ml/dl
—
7
29
883
8456
1.09
1.02
3.8
3.2
61.91
55.26
u/l
1.16
838
7706
18
115
1.57
0.99
2.1
2.2
—
—
—
0
0
13
76
1.72
0.99
1.1
1.3
—
—
—
0
0
9
49
1.84
0.98
1.0
1.1
—
—
—
0
0
30
217
1.39
0.93
2.3
2.3
113.99
205.09
u/ml
0.18
30
212
21
144
1.46
0.87
1.3
1.3
—
—
—
0
0
31
229
1.36
0.87
1.8
1.3
11.92
9.81
u/l
0.34
23
177
39
300
1.31
0.84
1.3
1.6
—
—
—
0
0
10
57
1.76
0.83
1.2
1.3
—
—
—
0
0
47
372
1.27
0.83
1.7
1.6
—
—
—
0
0
380
3544
1.09
0.80
1.7
1.7
424.10
25480358.42
pmol/l
2.58
319
2865
22
156
1.42
0.79
1.5
1.3
18347.08
72452.18
e6/l
0.65
13
108
15
98
1.54
0.78
1.0
1.1
—
—
—
0
0
15
98
1.54
0.78
1.0
1.1
—
—
—
0
0
18
123
1.47
0.77
1.2
1.1
—
—
—
0
0
15
99
1.52
0.75
1.0
1.1
—
—
—
0
0
15
99
1.52
0.75
1.0
1.1
—
—
—
0
0
15
99
1.52
0.75
1.0
1.1
—
—
—
0
0
14
91
1.54
0.75
1.4
1.2
0.03
0.61
u/ml
—
9
51
121
1064
1.15
0.74
2.3
2.2
12.08
12.66
nmol/l
0.29
102
925
484
5111
0.93
0.73
4.0
4.6
22.88
21.72
%
0.80
249
2661
10
60
1.67
0.72
1.0
1.1
—
—
—
0
0
9
57
1.58
0.71
1.3
1.0
—
—
—
0
0
21
152
1.39
0.69
1.0
1.1
—
—
—
0
0
233
2150
1.10
0.64
1.3
1.3
27.07
40.55
iu/ml
0.73
62
700
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
12
172
0.70
0.56
1.2
1.0
—
—
—
0
0
30
239
1.26
0.55
1.1
1.1
—
—
—
0
0
18
133
1.36
0.55
1.2
1.1
—
—
—
0
0
13
91
1.43
0.53
1.5
1.2
—
—
—
0
0
13
91
1.43
0.53
1.5
1.2
—
—
—
0
0
1202
11796
1.06
0.53
60.5
19.9
19.25
15.36
%
0.57
1189
11558
10
66
1.52
0.52
1.3
1.3
99.21
154.90
pmol/l
—
10
66
10
66
1.52
0.52
1.3
1.0
1.04
1.20
u/l
—
5
37
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
45
379
1.19
0.51
1.4
1.3
—
—
—
0
0
27
215
1.26
0.51
2.1
1.3
26.68
32.48
iu/l
0.40
22
180
12
84
1.43
0.49
1.8
1.8
20.74
17.57
nmol/l
0.41
12
74
11
154
0.71
0.47
2.5
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
115
1247
0.92
0.38
1.6
1.7
1.46
1.60
%
1.74
97
1032
23
279
0.82
0.37
1.3
1.3
—
—
—
0
0
42
367
1.15
0.34
3.9
3.7
24.37
28.26
mg/l
0.48
27
229
1064
10474
1.04
0.33
4.2
3.9
14.96
15.04
pmol/l
0.46
991
9273
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
76
695
1.10
0.31
1.1
1.2
110.86
136.87
iu/ml
0.26
27
248
15
120
1.25
0.30
1.1
1.1
0.10
1.44
u/ml
—
8
61
9
119
0.76
0.27
2.3
1.6
—
—
—
0
0
32
283
1.13
0.24
1.4
1.8
2.31
4.96
iu/l
3.01
11
91
12
97
1.24
0.23
1.0
1.4
0.82
1.03
promille
—
7
75
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
16
189
0.85
0.22
1.3
1.2
0.72
0.66
nmol/l
0.31
16
177
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
0.16
—
0
5
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
3970.33
—
0
6
5
43
1.16
0.21
1.2
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
29.62
—
0
13
0
13
0.00
0.21
0.0
1.0
—
0.13
—
0
6
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
7
58
1.21
0.18
2.0
2.7
—
—
—
0
0
7
58
1.21
0.18
2.0
2.7
—
—
—
0
0
11
91
1.21
0.17
2.3
1.7
—
—
—
0
0
17
149
1.14
0.15
1.5
1.4
24.64
27.83
%
0.15
11
97
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
517
5241
0.98
0.13
4.2
3.8
27.88
8.61
mg/mmol
3.99
391
3293
194
1988
0.97
0.12
3.9
4.9
32.82
33.15
%
0.15
147
1290
498
5044
0.98
0.11
3.4
3.2
7.03
7.26
mmol/l
0.58
437
4151
212
2075
1.02
0.11
1.2
1.2
7.78
13.87
u/ml
0.64
51
742
32
299
1.07
0.10
1.1
1.5
1.02
0.85
nmol/l
0.72
27
238
5
45
1.11
0.09
1.2
1.0
151.80
258.48
pmol/l
—
5
31
199
2029
0.98
0.09
12.9
8.0
—
—
—
0
0
44
420
1.05
0.08
2.3
2.2
79.01
101.58
ug/min
0.32
32
253
12
109
1.10
0.06
1.1
1.1
—
—
—
0
0
38
365
1.04
0.06
1.3
1.2
71.57
27.88
u/ml
—
6
17
53
547
0.97
0.06
1.1
1.0
—
—
—
0
0
638
6345
1.01
0.05
4.7
5.4
3.00
4.04
ug/l
0.72
567
5603
10
91
1.10
0.04
1.6
1.7
82.40
90.95
umol/l
—
10
91
14
146
0.96
0.00
1.8
1.3
—
—
—
0
0
36
354
1.02
0.00
1.4
1.2
1.42
8.36
u/ml
—
6
56
13
125
1.04
0.00
1.2
1.1
—
56.69
—
0
13
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.00
—
0
5
0
9
0.00
-0.00
0.0
1.3
—
2.67
—
0
9
8
83
0.96
-0.00
3.6
1.5
0.94
1.00
g/l
—
8
83
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
5
56
0.89
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.78
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1484.17
—
0
6
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MULTIPLE_MYELOMA_PLASMA_CELL – Multiple myeloma and malignant plasma cell neoplasms
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).